Small Nuclear Ribonucleoprotein Polypeptide N (SNRPN) is an essential gene found in the Prader-Willi syndrome (PWS) critical region in humans. It plays a key role in pre-mRNA splicing. SNRPN Activators would refer to a class of compounds that can modulate the activity of SNRPN, a gene involved in pre-mRNA splicing. The compounds listed above are selected based on their ability to influence the cellular processes and pathways that SNRPN is involved in. For instance, 5-Azacytidine, an inhibitor of DNA methylation, and Trichostatin A, a histone deacetylase inhibitor, can potentially affect the expression of SNRPN.
Other compounds, such as sodium butyrate, retinoic acid, and Dexamethasone can affect gene expression, cell differentiation, and immune responses, potentially influencing the function of SNRPN. Forskolin, genistein, and a range of DNA-interacting compounds (etoposide, doxorubicin, cisplatin, methotrexate, and daunorubicin) can affect various cellular processes and signaling pathways, potentially influencing the function or expression of SNRPN.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine can inhibit DNA methylation, potentially affecting the expression of SNRPN. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor that can potentially modulate the expression of SNRPN. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate can affect gene expression, potentially impacting the expression or function of SNRPN. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can affect cell differentiation and development, potentially influencing the function of SNRPN. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone can modulate immune responses, potentially affecting processes where SNRPN has a role. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin increases cAMP levels, potentially impacting intracellular signaling pathways that modulate SNRPN. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that may impact signaling pathways involving SNRPN. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide can interfere with topoisomerase II and thus affect DNA processes, potentially impacting SNRPN. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin can intercalate DNA and inhibit topoisomerase II, potentially affecting the function of SNRPN. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin can induce DNA damage, potentially affecting the function of SNRPN. | ||||||